Germany· DE-A57-4af262e70062686c
Buscopan Ampullen
A medicinal product containing hyoscine butylbromide, registered in Germany by A. Nattermann & Cie. Gmbh.
Checked against EMA Article 57 (European Union) on
Informational only — not a medical device.
The record
At a glance
EMA Article 57 (European Union)- Active substance
- Hyoscine Butylbromide
- Manufacturer
- A. Nattermann & Cie. Gmbh
- Country
- Germany (DE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- EMA Article 57 (European Union)
- Last checked
- August 5, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Hyoscine butylbromide in 10 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomBuscopan 10mg tabletsLexon (UK) Ltd
- BelgiumBuscafor 10 mg - 500 mgUPSA
- FinlandBumacorMacure Pharma ApS
- SwedenBumacor 20 mg/ml Injektionsvätska, lösningMACURE PHARMA ApS
- CzechiaBUSCOPANMayoly Pharma France, Rueil-Malmaison
- NetherlandsBuscopan, injectievloeistof 20 mg/mlEuro Registratie Collectief B.V.
- NorwayBumacorMacure Pharma ApS
- CanadaACCEL-HYOSCINEACCEL PHARMA INC
Authorised across Europe · EMA
The same active substance is authorised in 27 EEA countries. Names it is sold under:
- Austria · Buscapina, Buscopan
- Belgium · Buscopan, Buscopan Forte
- Bulgaria · Бусколизин, Бусколизин Форте
- Cyprus · Avotrin, Buscopan
- Czechia · Buscopan, Butylskopolaminium Bromid Kalceks
- Denmark · Bumacor
- Estonia · Bysimin
- Spain · Buscapina, Buscopresc
- Finland · Bumacor, Buscopan
- France · Buscopan, Scoburen
- United Kingdom (Northern Ireland) · Almus Ibs Relief, Almus Stomach Cramp Relief
- Greece · Avotrin, Buscopan
- Croatia · Buscopan, Bysimin
- Hungary · Buscopan, Buscopan Forte
- Ireland · Buscopan, Buscopan Ampoules
- Italy · Addofix, Buscopan
- Luxembourg · Buscopan, Buscopan Forte
- Latvia · Buscopan, Hyoscine Butylbromide Kalceks
- Malta · Buscopan, Buscopan Ampoules
- Netherlands · Buscopan, Scopolamine Butylbromide Kalceks
- Norway · Bumacor, Buscopan
- Poland · Aurogastro, Buscolysin
- Portugal · Buscopan, Butilescopolamina Conforpam
- Romania · Buscopan, Buscotil
- Sweden · Bumacor, Buscopan
- Slovenia · Buscopan
- Slovakia · Buscopan, Scopolamine Butylbromide Kalceks
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/cfcff3e5-cbcc-467b-b7c5-73a69ccc8a16 GET /v1/drugs/cfcff3e5-cbcc-467b-b7c5-73a69ccc8a16?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pzn": null,
"route": "Intramuscular Use, Intravenous Use, Subcutaneous Use",
"source": "ema_art57_de",
"ma_number": null,
"substance": "Hyoscine Butylbromide",
"atc_from_source": null,
"authorisation_country": "Germany"
}See everything about hyoscine butylbromide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.